Jeremy Slivnick, MD, Assistant Professor of Medicine at The University of Chicago Medical Center, discussed the promise of an artificial intelligence (AI) model designed to automatically analyze echocardiograms for signs of cardiac amyloid, particularly in older patients with heart failure and increased wall thickness.
High AIP linked to greater carotid atherosclerosis risk and progression, study finds.
Colchicine lowered arrhythmia, thrombosis after TAVR, but stroke risk led to early trial halt.
Dr. Kohli highlights the benefits of early, sustained LDL lowering for greater cardiovascular risk reduction and prevention.
High blood pressure and BMI will drive the global CVD burden through 2050, despite declines in age-standardized DALY rates.
In older AFib patients, bleeding raises death risk 4x, stroke nearly 2x—highlighting treatment complexities.
New AHA risk tool may underestimate heart disease in some groups, highlighting need for more accurate, equitable prediction.
Editorial Board
Amit Goyal, MDCo-Founder, CardioNerds
Payal Kohli, MD, FACCDr. Payal Kohli is a noninvasive cardiologist who provides insights on a plethora of preventative cardiologist topics.
Kevin M. Alexander, MDHeart failure expert at Stanford advancing care and research in cardiac amyloidosis and advanced heart failure.
Hady Lichaa, MDDr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.